TickerFiles

ACTUATE THERAPEUTICS, INC. 10-Q filing

Filed 2025-08-14 · Report date 2025-06-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001683168-25-006159
Form type
10-Q
CIK
0001652935
Primary document
https://www.sec.gov/Archives/edgar/data/1652935/000168316825006159/actuate_i10q-063025.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for ACTUATE THERAPEUTICS, INC..

Reported financial metrics

MetricCurrentPriorChange
Operating Income$-12.3M--
Net Income$-12.3M--
Eps Basic-0.63--
Eps Diluted-0.63--
Cash And Equivalents$6.5M--
Total Assets$7.0M--
Total Liabilities$9.6M--
Shareholders Equity$-2.7M--
Operating Cash Flow$-8.8M--